ANTI-EPHRIN B2 ANTIBODIES AND METHODS OF USE

AR135556A1Pending Publication Date: 2026-09-30MEDIAR THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ARP20250100788
Authority / Receiving Office
AR · AR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-03-27
Filing Date
2025-03-26
Publication Date
2026-09-30
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.

Claims

This document provides antibodies and antibody fragments that specifically bind to the ephrin B2 protein. The anti-ephrin B2 antibodies provided herein bind to the ephrin B2 protein with high affinity and specificity. Anti-ephrin B2 antibodies are considered effective for treating and preventing fibrosis in patients who require them.An anti-Ephrine B2 antibody comprising a heavy chain variable domain and a light chain variable domain, wherein said heavy chain variable domain comprises: a CDR H1 as set forth in SEQ ID No. 66, a CDR H2 as set forth in SEQ ID No. 67, and a CDR H3, wherein said CDR H3 is a variant of SEQ ID No. 68; wherein said light chain variable domain comprises: a CDR L1 as set forth in SEQ ID No. 69, a CDR L2 comprising LGS, and a CDR L3 as set forth in SEQ ID No. 70; and wherein said variant of SEQ ID No. 68 comprises the sequence of SEQ ID No. 68 including a substitution thereof at positions corresponding to position 4, position 6, position 10, and position 11 with respect to SEQ ID No. 68.